MA3 Paliperidone Palmitate Long-Acting Injection for Brazilian Non-Adherent Schizophrenic Patients: 5-Year Budget Impact Analysis From the Public Payer Perspective

Autor:	M.L. Pereira, L.S.K. Bahmdouni, A.D. Morais, V. Vitale, R.A. Fernandes, P.M.L. Santos, Maíra Libertad Soligo Takemoto
Rok vydání:	2012
Předmět:	Paliperidone Palmitate medicine.medical_specialty Long acting business.industry Health Policy Perspective (graphical) Public Health Environmental and Occupational Health medicine Budget impact Psychiatry business
Zdroj:	Value in Health. 15:A282
ISSN:	1098-3015
DOI:	10.1016/j.jval.2012.08.500
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::750cc7cf67430d8a7346f91f7c5053c3 https://doi.org/10.1016/j.jval.2012.08.500 Zobrazit plný text záznamu Full Text from ScienceDirect